The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Machine learning-based prediction of cytokine release syndrome post CAR-T cell therapy.
 
Jonas Paludo
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst)
Research Funding - Biofourmis (Inst); Karyopharm Therapeutics (Inst)
 
Jacob Shreve
Leadership - Ingensia AI Solutions
Stock and Other Ownership Interests - Ingensia AI Solutions
 
Emmanuel Contreras Guzman
No Relationships to Disclose
 
Arushi Khurana
No Relationships to Disclose
 
Prashant Kapoor
Honoraria - Abbvie (Inst); Abbvie (Inst); AstraZeneca; BeiGene; MustangBio; Pharmacyclics; Sanofi (Inst)
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Ichnos Sciences (Inst); Karyopharm Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Sanofi
 
Morie Gertz
No Relationships to Disclose
 
Yucai Wang
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Honoraria - Kite, a Gilead company (Inst)
Consulting or Advisory Role - Abbvie; AstraZeneca (Inst); BeiGene (Inst); Genmab (Inst); Incyte (Inst); Innocare (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Loxo (Inst); TG Therapeutics (Inst)
Research Funding - Abbvie (Inst); BeiGene (Inst); Genentech (Inst); Genmab (Inst); Incyte (Inst); InnoCare (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); MorphoSys (Inst); Novartis (Inst)
 
Moritz Binder
No Relationships to Disclose
 
Jose Villasboas
Consulting or Advisory Role - Curio Science (Inst); Kite/Gilead (Inst); Regeneron (Inst); TG Therapeutics (Inst)
Research Funding - Aptose Biosciences (Inst); Celgene/Bristol-Myers Squibb (Inst); Enterome (Inst); Epizyme (Inst); Genentech/Roche (Inst); Regeneron (Inst)
 
Nabila Bennani
Consulting or Advisory Role - Acrotech Biopharma (Inst); Affimed Therapeutics (Inst); Astellas Pharma (Inst)
Research Funding - Vyriad (Inst)
 
Patrick Johnston
No Relationships to Disclose
 
Muhamad Alhaj Moustafa
Consulting or Advisory Role - Abbvie; Cancer Network
 
Ricardo Parrondo
Consulting or Advisory Role - AstraZeneca; Sanofi Aventis GmbH
Research Funding - Bristol Myers Squibb Foundation; GlaxoSmithKline
Expert Testimony - MJH Life Sciences
 
Saurabh Chhabra
Honoraria - GlaxoSmithKline; Janssen Oncology; Sanofi
Research Funding - Abbvie (Inst); C4 Therapeutics (Inst); CARsgen Therapeutics (Inst); Janssen (Inst)
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Beigene; Janssen; Pfizer
 
Stephen Ansell
Honoraria - Answers in CME; Medscape; Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Step Pharma (Inst); Takeda (Inst)
 
Allison Rosenthal
Honoraria - OncLive/MJH Life Sciences
Consulting or Advisory Role - Curio Science; Curio Science; Curio Science; RMEI Medical Education; Targeted Oncology; Targeted Oncology; Targeted Oncology
 
Mohamed Kharfan-Dabaja
Honoraria - Kite/Gilead
Research Funding - Bristol Myers Squibb (Inst); Novartis (Inst); Pharmacyclics (Inst)
 
Tufia Haddad
Research Funding - Puma Biotechnology (Inst); Takeda (Inst)
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tessera (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)